You are here
P&T November 2019
Two decades after the landmark To Err Is Human report was published, patient safety has improved but medication errors remain a significant problem.
Amantadine had the highest response rate as an awakening agent among TBI patients in the ICU in this retrospective chart review study.
Shouldn’t engaging physicians in formulary decisions improve formulary adherence? This study at an academic medical center found otherwise.
Digital health products are coming on strong, and P&T committees and health care professionals will have to manage their use.
CMS proposes new standard electronic prior authorization.
Workarounds may get the job done but may let long-term problems fester.
Rozlytrek (entrectinib) for ROS-1 positive metastatic non–small-cell lung cancer and NTRK gene fusion positive solid tumors
Evenity (romosozumab-aqqg) for osteoporosis in post-menopausal women at high risk for fracture